ORXE Insider Trading Activity and SEC Form 4 Filings
ORXE insider trading summary
No open-market insider purchases or sales of Ore Pharmaceutical Holdings Inc. (ORXE) have been reported on SEC Form 4 in the past 12 months.
Latest ORXE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 30, 2009 | Mark J Gabrielson | Chief Executive Officer | Buy | $1K (2,000 @ $0.62) |
| Nov 27, 2009 | James W Fordyce | Director | Buy | $1K (2,000 @ $0.55) |
| Nov 25, 2009 | James W Fordyce | Director | Buy | $1K (2,000 @ $0.57) |
| Nov 23, 2009 | James W Fordyce | Director | Buy | $1K (2,000 @ $0.57) |
| Nov 20, 2009 | James W Fordyce | Director | Buy | $1K (2,000 @ $0.64) |
| Nov 18, 2009 | Mark J Gabrielson | Chief Executive Officer | Buy | $12 (20 @ $0.62) |
| Nov 18, 2009 | James W Fordyce | Director | Buy | $190 (300 @ $0.63) |
| Nov 18, 2009 | James W Fordyce | Director | Buy | $1K (1,700 @ $0.63) |
| Nov 18, 2009 | Mark J Gabrielson | Chief Executive Officer | Buy | $1K (1,980 @ $0.64) |
| Nov 17, 2009 | Mark J Gabrielson | Chief Executive Officer | Buy | $1K (2,000 @ $0.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.